Compounds > sr141716
Page last updated: 2024-08-26

sr141716 and am4113

sr141716 has been researched along with am4113 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's7 (77.78)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergman, J; Delatte, MS; Makriyannis, A; Paronis, CA; Thakur, GA; Vemuri, K1
Järbe, TU; LeMay, BJ; Makriyannis, A; Olszewska, T; Vemuri, VK; Wood, JT1
Bashashati, M; Duncan, M; Hirota, C; Keenan, CM; Lutz, B; Mackie, K; Macnaughton, WK; Makriyannis, A; Sharkey, KA; Storr, MA; Vemuri, VK1
Järbe, TU; LeMay, BJ; Makriyannis, A; Vadivel, SK; Vemuri, VK; Zvonok, A1
Bergman, J; Delatte, MS; Kangas, BD; Makriyannis, A; Nikas, SP; Shukla, VG; Subramanian, KV; Thakur, GA; Vemuri, VK1
Järbe, TU; Makriyannis, A; Nikas, SP; Shukla, VG; Tai, S; Vemuri, K1
Bergman, J; Goldberg, SR; Justinova, Z; Le Foll, B; Makriyannis, A; Redhi, GH; Schindler, CW; Vemuri, K1
Antoniou, K; Delis, F; Gueye, AB; Laviolette, SR; Le Foll, B; Loureiro, M; Makriyannis, A; Poulia, N; Pryslawsky, Y; Trigo, JM; Vemuri, K1
Baumann, MH; Gramling, BR; Justinova, Z; Schindler, CW; Thorndike, EB1

Reviews

1 review(s) available for sr141716 and am4113

ArticleYear
Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties.
    Physiology & behavior, 2008, Mar-18, Volume: 93, Issue:4-5

    Topics: Animals; Behavior, Animal; Conditioning, Operant; Drug Interactions; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant

2008

Other Studies

8 other study(ies) available for sr141716 and am4113

ArticleYear
Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
    Pharmacology, biochemistry, and behavior, 2008, Volume: 91, Issue:1

    Topics: Animals; Behavior, Animal; Benzoxazines; Defecation; Dose-Response Relationship, Drug; Grooming; Injections, Intraperitoneal; Male; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Urination; Vocalization, Animal

2008
Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.
    Neurogastroenterology and motility, 2010, Volume: 22, Issue:7

    Topics: Animals; Colon; Epithelium; Feces; Gastrointestinal Motility; Gastrointestinal Transit; Ileum; Immunohistochemistry; Ions; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth; Permeability; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Water

2010
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
    Psychopharmacology, 2011, Volume: 216, Issue:3

    Topics: Animals; Arachidonic Acids; Cannabinoids; Discrimination, Psychological; Dose-Response Relationship, Drug; Drinking; Dronabinol; Indoles; Ligands; Male; Morpholines; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors

2011
Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.
    The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:3

    Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoids; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Ligands; Male; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Saimiri

2013
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist.
    Psychopharmacology, 2015, Volume: 232, Issue:15

    Topics: Animals; Body Temperature; Cannabinoid Receptor Antagonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Tolerance; Male; Mice; Morpholines; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance Withdrawal Syndrome

2015
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:9

    Topics: Animals; Conditioning, Operant; Cues; Dronabinol; Drug-Seeking Behavior; Male; Marijuana Abuse; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Recurrence; Reinforcement, Psychology; Rimonabant; Saimiri; Self Administration; Tobacco Use Disorder

2016
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    The international journal of neuropsychopharmacology, 2016, Volume: 19, Issue:12

    Topics: Animals; Anxiety; Behavior, Addictive; Behavior, Animal; Cannabinoid Receptor Antagonists; Cues; Depression; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Inverse Agonism; Drug-Seeking Behavior; Male; Maze Learning; Mesencephalon; Motivation; Motor Activity; Piperidines; Pyrazoles; Rats, Long-Evans; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction; Swimming; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Weight Loss

2016
Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.
    Drug and alcohol dependence, 2017, 10-01, Volume: 179

    Topics: Animals; Body Temperature; Cannabinoids; Cannabis; Dronabinol; Indoles; Male; Naphthalenes; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Spices

2017